FDA bars from industry man convicted of selling foreign-made drugs

Talib Khan is already doing time in federal facility in Philadelphia, but the FDA has let him know that once he is out, he is barred from ever working for any company that sells FDA-approved drugs. Khan was one of the owners of the Arlington, VA-based Gallant Pharma International. The feds closed the company in 2013 for selling foreign versions of Botox and cancer drugs on the black market, often receiving the drugs in a condition that left their quality and sterility in question. Khan and his partner, Syed "Farhan" Huda, and employees of the company pleaded guilty to federal charges in 2013. Here's a notice of the ban (PDF) | More

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.